Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...

"I congratulate the government and people of Burundi and commend them for their hard work and dedication. The elimination of ...

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry ...

Dallas Mavericks star Anthony Davis has undergone surgery on a detached retina, according to ESPN. Davis suffered the injury ...

Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...

Each year, more than 30 million people globally receive surgery to correct cataracts. As many people age, the crystalline ...

Longer axial lengths, preoperative glaucoma drop use appear to raise the risk for hypotony following vitrectomy for epiretinal membrane.

Three surgical techniques for aphakia correction each provide good refractive, visual acuity, and safety outcomes.